Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress
Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress Faheem Tahir Sat, November 29, 2025 at 2:26 PM GMT+8 2 min read In this article: ZURA +1.05% With strong thr...